Bojan Polić

Publications

  1. Polic B., Lazarevic D., Finderle A. and Linić-Vlahovic V. (1988) Early inflammatory response to skin allograft in the rat. Iugoslav. Physiol. Pharmacol. Acta 24(6):355-356.
  2. Lucin P., Pavic I., Polic B., Jonjic S., and U.H. Koszinowski (1992). Gamma interferon‑dependent clearance of cytomegalovirus infection in salivary glands. J. Virol., 66:1977‑1984.
  3. Lucin P., Polic B., Crnkovic I., Lucin K., Rukavina D. and Jonjic S. (1992) Involvment of CD4+ T lymphocytes and macrophages in low-dose streptozotocin-induced diabetes in CBA mice. Cro. Med. J. 33(1):9-16.
  4. Pavic I., Polic B., Crnkovic I., Lucin P., Jonjic S., and Koszinowski U.H. (1993). Participation of Endogenous Tumor Necrosis Factor Alpha in Host Resistance to Cytomegalovirus Infection. J. Gen. Virol. 74:2215‑2223
  5. Polic. B., Pavic I., Crnkovic I., Lucin P., Trobonjaca Z., and Jonjic S. (1993). The Role of CD4+ and CD8+ T Lymphocytes in Viral Immunity. Cro. Med. J. 34(4):294‑300.
  6. Lucin P., Jonjic S., Messerle M., Polic B., Hengel H. and Koszinowski U.H. (1994) Late phase inhibition of murine cytomegalovirus replication hy synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:101-110.
  7. Jonjic S., Pavic I., Polic B., Crnkovic I., Lucin P., and Koszinowski U.H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713-1717.
  8. Lučin P., Jonjić S., Hengel H., Pavić I., Polić B., Crnković I., Thale R., Zorica I., and Koszinowski U.H.. (1994). Cytomegalovirus persistence in salivary glands by evasion from immunological control. Regional Immunology 6:391-396.
  9. Radosevic-Stasic B., Trobonjaca Z.,  Lucin P., Cuk M., Polic B., Rukavina D. and   Efendic S. (1995) Immunosuppressive  and  antiproliferative  effects of  somatostatin analog  SMS 201-995. Intern. J. Neuroscience 81:283-297.
  10. Polic B., Jonjic S., Pavic I., Crnkovic I., Zorica I., Hengel H., Kucic N., Lucin P., and Koszinowski U.H.. (1995). Control of cytomegalovirus infection in MHC class I deficient mice. Scand. J. Infect. Dis. 99:52-53.
  11. Polic B. ,  Jonjic S.,  Pavic I.,    Crnkovic I.,    Zorica I.,     Hengel H.,  Lucin P.,  and Koszinowski U. H.. (1996). Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 77:217-225.
  12. Polic B., Hengel H., Krmpotic A., Trgovchich J.,  Pavic I.,  Lucin P.,  Jonjic S. and    Koszinowski U.H.. (1998).  Hierarchical  and   Redundant   Lymphocyte   Subset   Control     Precludes  Cytomegalovirus  Replication   during   Latent   Infection.  J.  Exp.  Med. 188:1047-1054.
  13. Krmpotic A.,    Messerle M.,    Crnkovic-Mertens I.,    Polić B.,   Jonjić S. and   Koszinowski U.H.. (1999). The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 Protects the Virus Against T Cell Control in Vivo. J. Exp. Med. 190:1285-96.
  14. Trgovcich J, Stimac D, Polic B, Krmpotic A, Pernjak-Pugel E, Tomac J, Hasan M, Wraber B, Jonjic S. (2000) Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Arch. Virol. 145:2601-18.
  15. Polic B., Kunkel D., Scheffold A., and Rajewsky K. (2001) How alpha beta T cells deal with induced TCRalpha  ablation. Proc. Natl. Aacad. Sci. USA 98:8744-8749.
  16. Hasan M., Polic B., Bralic M., Jonjic S.and Rajewsky K. (2002) Incomplete block of B cell development and immunoglobulin production in mice carrying the MT mutation on the BALB/c background. Eur. J. Immunol. 32:3463-71.
  17. A. Krmpotic, I. Bubic, B. Polic, P. Lucin and S. Jonjic (2003) Pathogenesis of murine cytomegalovirus infection. Microbes Infect. 5:1263-77.
  18. A. Krmpotić, M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegskorte, E. Pernjak-Pugel, M. Messerle, H. Hengel, D.H. Busch, U.H. Koszinowski and S. Jonjic (2005) NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201:211-20
  19. Buch T., Polic B., Clausen BE., Weiss S., Akilli-Ozturk O., Chang CH, Flavell R., Schulz A., Jonjic S., Waisman A. and Forster I (2006) MHC class II expression through a hitherto unknown pathway supports T helper cell dependent immune responses: implications for MHC class II deficiency. Blood, 107:434-44.
  20. Taussig MJ, Stoevesandt O, Borrebaeck CA, Bradbury AR, Cahill D, Cambillau C, de Daruvar A, Dübel S, Eichler J, Frank R, Gibson TJ, Gloriam D, Gold L, Herberg FW, Hermjakob H, Hoheisel JD, Joos TO, Kallioniemi O, Koegl M, Konthur Z, Korn B, Kremmer E, Krobitsch S, Landegren U, van der Maarel S, McCafferty J, Muyldermans S, Nygren PA, Palcy S, Plückthun A, Polić B, Przybylski M, Saviranta P, Sawyer A, Sherman DJ, Skerra A, Templin M, Ueffing M, Uhlén M. (2007) ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nature Methods 4:13-17
  21. Jonjić S, Babić M, Polić B, Krmpotić A. (2008) Immune evasion of natural killer cells by viruses. Current Opinion in Immunology 20:30-38 22. Jonjić S, Polić B, Krmpotić A. (2008) Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance? Eur. J. Immunol. 38:2952-2956
  22. Arapovic J, Lenac T, Antulov R, Polić B, Ruzsics Z, Carayannopoulos LN, Koszinowski UH, Krmpotic A, Jonjic S. (2009) Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.J. Virol. 83:8198 – 8207
  23. Zafirova B, Mandarić S, Antulov R, Krmpotić A, Jonsson H, Yokoyama WM, Jonjić S, Polić B. (2009) Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31:270 – 282